These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24123098)

  • 21. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Hibi K; Sozu T; Terashima M; Michishita I;
    Coron Artery Dis; 2013 Sep; 24(6):481-6. PubMed ID: 23751736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
    Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
    Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
    Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
    Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
    Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I
    Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
    Egede R; Jensen LO; Hansen HS; Hansen KN; Junker A; Thayssen P
    EuroIntervention; 2013 Feb; 8(10):1182-9. PubMed ID: 22987572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC
    Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the efficacy of statin treatment in acute coronary syndromes.
    Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
    Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
    Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
    Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of statin therapy on non-calcified coronary plaque assessed by 64-slice computed tomography.
    Kitagawa T; Yamamoto H; Horiguchi J; Ohashi N; Kunita E; Utsunomiya H; Kihara Y
    Int J Cardiol; 2011 Jul; 150(2):146-50. PubMed ID: 20542581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies.
    Taguchi I; Oda K; Yoneda S; Kageyama M; Kanaya T; Toyoda S; Abe S; Node K; Inoue T
    Am J Cardiol; 2013 May; 111(9):1246-52. PubMed ID: 23411102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia.
    Ramunni A; Brescia P; Dambra P; Capuzzimati L; Ria R; De Tullio G; Resta F; Russi G; Vacca A; Coratelli P
    Blood Purif; 2010; 29(4):383-9. PubMed ID: 20484899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus.
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    J Diabetes Complications; 2015; 29(1):142-5. PubMed ID: 25456820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
    von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
    Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.